Medicine
Adenosine 12 mg/4 mL injection
Adenosine 12 mg/4 mL injection is a generic prescription medicine for intravenous use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. DO NOT REFRIGERATE as crystallization may occur. Store at 20°…
Key facts
- Active ingredient (INN)
- Adenosine
- Brand
- Sold under the generic name
- Strength
- 12 mg/4 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 syringes of 4 mL, 10 vials of 4 mL, 10 pouches of 4 mL and 7 more
- Manufacturers
- Gland PharmaIndiaFresenius KabiHealthFirstSagent PharmaceuticalsMylan InstitutionalRemedyrepack
- Origin register
- US FDA, United States
- Storage
- Do not freeze. DO NOT REFRIGERATE as crystallization may occur. Store at 20° to 25°C (68° to 77°F). If crystallization has occurred, dissolve crystals by warming to room temperature.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01EB10 Adenosine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 November 2005
- Identifiers
- RxCUI 727355, 727360, 1654186 +3DailyMed set ID 5a55b45d-9cee-4c0c-9e44-021dbf70a018, 996fc80e-b680-31f1-e053-2995a90aa0f1, 6785cf30-360f-409b-a4b2-fc910728f01f +7NDC 25021-301, 51662-1450, 63323-651 +6Application ANDA077283, ANDA077133, ANDA205568 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 syringe in 1 carton / 4 mL in 1 syringe | 68083-101-02 | Gland PharmaIndia | 1 April 2013 |
| 10 vial in 1 carton / 4 mL in 1 vial | 68083-157-10 | Gland PharmaIndia | 13 January 2017 |
| 10 vial, single-use in 1 tray / 4 mL in 1 vial, single-use | 63323-651-04 | Fresenius Kabi | 23 November 2005 |
| 10 syringe, plastic in 1 carton / 4 mL in 1 syringe, plastic | 63323-651-90 | Fresenius Kabi | 16 April 2018 |
| 10 syringe in 1 carton / 4 mL in 1 syringe | 25021-301-68 | Sagent Pharmaceuticals | 16 April 2014 |
| 10 vial in 1 carton / 4 mL in 1 vial | 25021-318-04 | Sagent Pharmaceuticals | 15 March 2023 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 67457-854-04 | Mylan Institutional | 8 May 2018 |
| 10 pouch in 1 case / 1 vial, single-use in 1 pouch / 4 mL in 1 vial, single-use | 51662-1450-3 | HealthFirst | 11 December 2019 |
| 1 syringe in 1 carton / 4 mL in 1 syringe | 51662-1511-1 | HealthFirst | 21 January 2021 |
| 10 vial in 1 carton / 4 mL in 1 vial | 70518-4207-2 | Remedyrepack | 6 December 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 October 1989 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Adenosine
Clinical summary
Adenosine is an adenosine receptor agonist indicated for the following. It is available as injection for intravenous use. MedsAcross supplies Adenosine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AdenosineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Adenosine prescribing information (Sagent Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Adenosine 12 mg/4 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.